Top compounds associated with response to RP11-96O20.4


Feature Type Standardized
Nominal ANOVA
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.087 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.01
mRNA YM-155 CTRPv2 pan-cancer AAC -0.097 0.01
mRNA AZD6244 UHNBreast pan-cancer AAC 0.67 0.01
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.01
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.01
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.082 0.01
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.082 0.01
mRNA NSC95397 CTRPv2 pan-cancer AAC -0.083 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.02
Download CSV